Autopsy report · NCT01438151

Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease

“terminated due to poor enrollment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 2 years before it stopped.
• 11 participants enrolled.
• Results were posted on the registry 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Shradha Agarwal

Sponsor type

University, hospital or other

Conditions

Crohn's Disease

Interventions

Remicade

Participants

11

Sites

1

Countries

United States

Trials that died the same way

• Polycystic Liver Disease in Kidney Transplant
  “Terminated due to inadequate enrollment” (97% match in meaning)
• Study of Maternal Hepatitis C Infection and Influenza Vaccination in Pregnancy
  “Terminated due to lack of enrollment” (96% match in meaning)
• Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer
  “Terminated early due to poor enrollment” (91% match in meaning)
• Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
  “Terminated due to low enrollment.” (90% match in meaning)
• Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia
  “Terminated due to low enrollment rate.” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.